RxDoctor Payments Data

Melanie Haddad

Pain Medicine · Utica, NYNPI 1770246878

Payments from drug & device makers

$4,929in general payments, 2019–2025

Across 91 payments — averaging $54.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Globus Medical$294
  • SPR Therapeutics, Inc$275
  • AbbVie$260
  • Johnson & Johnson$244
  • Collegium Pharmaceutical, Inc.$167
  • plus $831 from 15 others

What the payments were for

  • Travel & lodging$1,50831%
  • Food & beverage$3,42069%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,929 in reported general payments places this provider in the 70th percentile of 503 pain medicine providers in New York.

See all pain medicine providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl26$19,354
Pregabalin104$7,310
Xtampza ErOxycodone Myristate14$6,050
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen277$5,181
Lidocaine18$2,713
Gabapentin180$2,438
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen80$1,717
Tizanidine Hcl97$1,233
Tramadol Hcl ErTramadol Hcl15$863
Tramadol Hcl81$771
Diclofenac Sodium21$635
Celecoxib26$548
Cyclobenzaprine Hcl81$530
Oxycodone Hcl39$506
Baclofen58$390

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$167$6,05014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 503 pain medicine providers in New York.

Other pain medicine in Utica

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →